BACKGROUND AND PURPOSE: Ketone bodies provide important alternate fuel for brain metabolism, and their transport into the brain increases with prolonged fasting. During diabetic ketoacidosis (DKA), serum ketone concentrations markedly increase; however, little is known about whether ketone bodies accumulate in cerebral tissues during DKA. We used proton MR spectroscopy (MRS) to detect cerebral beta-hydroxy butyrate (betaOHB) and acetone/acetocaetate (AcAc) in children with DKA. METHODS: Twenty-five children underwent brain MRS: nine within 4 hours of the start of treatment for DKA; 11, at 4-8 hours; and five, at 8-12 hours. MRS was repeated after their recovery from the DKA episode at > or =72 hours after the start of treatment. MRS was evaluated for peaks corresponding to betaOHB (doublet centered on 1.20 ppm) and lactate (doublet centered on 1.33 ppm). Difference spectroscopy was used to identify the AcAc peak at 2.22-2.26 ppm. RESULTS: betaOHB was detected in 13 children (52%), more frequently within 4 hours (eight children, 89%) than after 4 hours (five children, 31%). AcAc was detected in 15 children (60%), more frequently at >4 hours after the start of treatment (12 patients, 75%) than in the first 4 hours (three patients, 33%). Lactate was detected in five children (18%), all within the first 8 hours of treatment. CONCLUSION: In children, betaOHB and AcAc accumulate in the brain during DKA, and they can be detected on MRS. Care should be taken in interpreting MRS results in patients with DKA to avoid erroneously attributing betaOHB peaks to lactate.
BACKGROUND AND PURPOSE:Ketone bodies provide important alternate fuel for brain metabolism, and their transport into the brain increases with prolonged fasting. During diabetic ketoacidosis (DKA), serum ketone concentrations markedly increase; however, little is known about whether ketone bodies accumulate in cerebral tissues during DKA. We used proton MR spectroscopy (MRS) to detect cerebral beta-hydroxy butyrate (betaOHB) and acetone/acetocaetate (AcAc) in children with DKA. METHODS: Twenty-five children underwent brain MRS: nine within 4 hours of the start of treatment for DKA; 11, at 4-8 hours; and five, at 8-12 hours. MRS was repeated after their recovery from the DKA episode at > or =72 hours after the start of treatment. MRS was evaluated for peaks corresponding to betaOHB (doublet centered on 1.20 ppm) and lactate (doublet centered on 1.33 ppm). Difference spectroscopy was used to identify the AcAc peak at 2.22-2.26 ppm. RESULTS:betaOHB was detected in 13 children (52%), more frequently within 4 hours (eight children, 89%) than after 4 hours (five children, 31%). AcAc was detected in 15 children (60%), more frequently at >4 hours after the start of treatment (12 patients, 75%) than in the first 4 hours (three patients, 33%). Lactate was detected in five children (18%), all within the first 8 hours of treatment. CONCLUSION: In children, betaOHB and AcAc accumulate in the brain during DKA, and they can be detected on MRS. Care should be taken in interpreting MRS results in patients with DKA to avoid erroneously attributing betaOHB peaks to lactate.
Authors: Barbara Plecko; Sylvia Stoeckler-Ipsiroglu; Edith Schober; Georg Harrer; Vladimir Mlynarik; Stephan Gruber; Ewald Moser; Dorothea Moeslinger; Heinz Silgoner; Osman Ipsiroglu Journal: Pediatr Res Date: 2002-08 Impact factor: 3.756
Authors: Nicole S Glaser; Daniel J Tancredi; James P Marcin; Ryan Caltagirone; Yvonne Lee; Christopher Murphy; Nathan Kuppermann Journal: J Pediatr Date: 2013-07-18 Impact factor: 4.406
Authors: Amro Ilaiwy; Miao Liu; Traci L Parry; James R Bain; Christopher B Newgard; Jonathan C Schisler; Michael J Muehlbauer; Florin Despa; Monte S Willis Journal: Metabolomics Date: 2016-04-23 Impact factor: 4.290
Authors: Jakob Heimer; Dominic Gascho; Vasiliki Chatzaraki; Damaris Fröhlich Knaute; Vera Sterzik; Rosa Maria Martinez; Michael J Thali; Niklaus Zoelch Journal: Int J Legal Med Date: 2017-11-23 Impact factor: 2.686
Authors: Christopher M Horvat; Heba M Ismail; Alicia K Au; Luigi Garibaldi; Nalyn Siripong; Sajel Kantawala; Rajesh K Aneja; Diane S Hupp; Patrick M Kochanek; Robert Sb Clark Journal: Pediatr Diabetes Date: 2018-04-26 Impact factor: 4.866
Authors: S L Wootton-Gorges; M H Buonocore; N Kuppermann; J P Marcin; P D Barnes; E K Neely; J DiCarlo; T McCarthy; N S Glaser Journal: AJNR Am J Neuroradiol Date: 2007-05 Impact factor: 3.825